- Details
- Written by White House
- Category: Health News
Washington, DC - Building on President Obama’s announcement in his State of the Union Address, today the Administration is unveiling details about the Precision Medicine Initiative, a bold new research effort to revolutionize how we improve health and treat disease. Launched with a $215 million investment in the President’s 2016 Budget, the Precision Medicine Initiative will pioneer a new model of patient-powered research that promises to accelerate biomedical discoveries and provide clinicians with new tools, knowledge, and therapies to select which treatments will work best for which patients.
- Details
- Written by IVN
- Category: Health News
Rancho Dominguez, California - At the request of the U.S. Food and Drug Administration, a federal judge from the U.S. District Court for the Central District of California today entered a consent decree of permanent injunction against Laclede, Inc. of Rancho Dominguez, California, and its president, Michael A. Pellico. Laclede is the manufacturer of Luvena Prebiotic products.
- Details
- Written by IVN
- Category: Health News
San Francisco, California - It’s an old maxim that to get a job done right you need the right tools, that’s why CIRM, California’s stem cell agency, today approved $29.75 million in funding for new approaches to overcome obstacles and advance stem cell research.
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration announced today that it will strengthen its review of automated external defibrillators (AEDs) to help improve the quality and reliability of these devices.
- Details
- Written by IVN
- Category: Health News
Sacramento, California - California Department of Public Health (CDPH) director and state health officer Dr. Ron Chapman issued a Health Advisory and the “State Health Officer’s Report on E-Cigarettes: A Community Health Threat,” warning Californians of the toxicity of electronic cigarettes (e-cigarettes).
- Details
- Written by Natalie van Hoose
- Category: Health News
West Lafayette, Indiana - Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue University study finds.
Page 335 of 374
